Structural basis by which a recessive mutation in the α-subunit of the insulin receptor affects insulin binding

Mohammed Taouis, Rachel Levy-Toledano, Paris Roach, Simeon I. Taylor, Phillip Gorden

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Recently, a mutation substituting Leu for Ser323 in the α-subunit of the human insulin receptor has been identified in an insulin-resistant patient. The Leu323 mutation leads to a severe impairment in insulin binding without significantly altering the processing or cell surface expression of the receptor. In order to study how αβ half-receptors interact to form the insulin-binding site, we cotransfected NIH-3T3 cells with two insulin receptor cDNA constructs: a truncated insulin receptor lacking the C-terminal 43 amino acids (Δ43) and the full-length Leu323 mutant receptor. A clonal cell line from cotransfected cells expresses a hybrid receptor consisting of a Leu323 half-receptor and a Δ43 half- receptor. We demonstrate that the Leu323-Δ43 hybrid receptor binds insulin with high affinity. Furthermore, by cross-linking 125I-insulin to immobilized hybrid receptors, we show that only the αβ(Δ) half of the hybrid receptor binds insulin. Since the isolated half-insulin receptor has low affinity for insulin, this suggests that the addition of even a non- binding α-subunit can result in high affinity binding to the holoreceptor (αα(mut)β(Δ)β). Both β and β(Δ)-subunits of the Leu323-Δ43 hybrid receptor are phosphorylated in vivo and in vitro in an insulin-dependent manner, suggesting an intramolecular transphosphorylation mechanism and that the presence of the Leu323 mutant receptor that lacks an intrinsic high affinity binding site does not prevent the associated β-subunit from functioning either as a tyrosine kinase or as a phosphate acceptor in the hybrid insulin receptor molecule (αα(mut)β(Δ)β). Furthermore, we show that the hybrid receptor can phosphorylate insulin receptor substrate-1 (IRS- 1) in response to insulin and can be coimmunoprecipitated together with IRS- 1 by anti-IRS-1 antibody.

Original languageEnglish (US)
Pages (from-to)14912-14918
Number of pages7
JournalJournal of Biological Chemistry
Volume269
Issue number21
StatePublished - May 27 1994
Externally publishedYes

Fingerprint

Insulin Receptor
Insulin
Mutation
Insulin Receptor Substrate Proteins
Binding Sites
NIH 3T3 Cells
Cell Surface Receptors
Protein-Tyrosine Kinases
Complementary DNA
Phosphates
Cells
Amino Acids
Cell Line
Molecules
Antibodies
Processing

ASJC Scopus subject areas

  • Biochemistry

Cite this

Structural basis by which a recessive mutation in the α-subunit of the insulin receptor affects insulin binding. / Taouis, Mohammed; Levy-Toledano, Rachel; Roach, Paris; Taylor, Simeon I.; Gorden, Phillip.

In: Journal of Biological Chemistry, Vol. 269, No. 21, 27.05.1994, p. 14912-14918.

Research output: Contribution to journalArticle

Taouis, Mohammed ; Levy-Toledano, Rachel ; Roach, Paris ; Taylor, Simeon I. ; Gorden, Phillip. / Structural basis by which a recessive mutation in the α-subunit of the insulin receptor affects insulin binding. In: Journal of Biological Chemistry. 1994 ; Vol. 269, No. 21. pp. 14912-14918.
@article{10784fa3aa3d4880a744ab1ce26df5d3,
title = "Structural basis by which a recessive mutation in the α-subunit of the insulin receptor affects insulin binding",
abstract = "Recently, a mutation substituting Leu for Ser323 in the α-subunit of the human insulin receptor has been identified in an insulin-resistant patient. The Leu323 mutation leads to a severe impairment in insulin binding without significantly altering the processing or cell surface expression of the receptor. In order to study how αβ half-receptors interact to form the insulin-binding site, we cotransfected NIH-3T3 cells with two insulin receptor cDNA constructs: a truncated insulin receptor lacking the C-terminal 43 amino acids (Δ43) and the full-length Leu323 mutant receptor. A clonal cell line from cotransfected cells expresses a hybrid receptor consisting of a Leu323 half-receptor and a Δ43 half- receptor. We demonstrate that the Leu323-Δ43 hybrid receptor binds insulin with high affinity. Furthermore, by cross-linking 125I-insulin to immobilized hybrid receptors, we show that only the αβ(Δ) half of the hybrid receptor binds insulin. Since the isolated half-insulin receptor has low affinity for insulin, this suggests that the addition of even a non- binding α-subunit can result in high affinity binding to the holoreceptor (αα(mut)β(Δ)β). Both β and β(Δ)-subunits of the Leu323-Δ43 hybrid receptor are phosphorylated in vivo and in vitro in an insulin-dependent manner, suggesting an intramolecular transphosphorylation mechanism and that the presence of the Leu323 mutant receptor that lacks an intrinsic high affinity binding site does not prevent the associated β-subunit from functioning either as a tyrosine kinase or as a phosphate acceptor in the hybrid insulin receptor molecule (αα(mut)β(Δ)β). Furthermore, we show that the hybrid receptor can phosphorylate insulin receptor substrate-1 (IRS- 1) in response to insulin and can be coimmunoprecipitated together with IRS- 1 by anti-IRS-1 antibody.",
author = "Mohammed Taouis and Rachel Levy-Toledano and Paris Roach and Taylor, {Simeon I.} and Phillip Gorden",
year = "1994",
month = "5",
day = "27",
language = "English (US)",
volume = "269",
pages = "14912--14918",
journal = "Journal of Biological Chemistry",
issn = "0021-9258",
publisher = "American Society for Biochemistry and Molecular Biology Inc.",
number = "21",

}

TY - JOUR

T1 - Structural basis by which a recessive mutation in the α-subunit of the insulin receptor affects insulin binding

AU - Taouis, Mohammed

AU - Levy-Toledano, Rachel

AU - Roach, Paris

AU - Taylor, Simeon I.

AU - Gorden, Phillip

PY - 1994/5/27

Y1 - 1994/5/27

N2 - Recently, a mutation substituting Leu for Ser323 in the α-subunit of the human insulin receptor has been identified in an insulin-resistant patient. The Leu323 mutation leads to a severe impairment in insulin binding without significantly altering the processing or cell surface expression of the receptor. In order to study how αβ half-receptors interact to form the insulin-binding site, we cotransfected NIH-3T3 cells with two insulin receptor cDNA constructs: a truncated insulin receptor lacking the C-terminal 43 amino acids (Δ43) and the full-length Leu323 mutant receptor. A clonal cell line from cotransfected cells expresses a hybrid receptor consisting of a Leu323 half-receptor and a Δ43 half- receptor. We demonstrate that the Leu323-Δ43 hybrid receptor binds insulin with high affinity. Furthermore, by cross-linking 125I-insulin to immobilized hybrid receptors, we show that only the αβ(Δ) half of the hybrid receptor binds insulin. Since the isolated half-insulin receptor has low affinity for insulin, this suggests that the addition of even a non- binding α-subunit can result in high affinity binding to the holoreceptor (αα(mut)β(Δ)β). Both β and β(Δ)-subunits of the Leu323-Δ43 hybrid receptor are phosphorylated in vivo and in vitro in an insulin-dependent manner, suggesting an intramolecular transphosphorylation mechanism and that the presence of the Leu323 mutant receptor that lacks an intrinsic high affinity binding site does not prevent the associated β-subunit from functioning either as a tyrosine kinase or as a phosphate acceptor in the hybrid insulin receptor molecule (αα(mut)β(Δ)β). Furthermore, we show that the hybrid receptor can phosphorylate insulin receptor substrate-1 (IRS- 1) in response to insulin and can be coimmunoprecipitated together with IRS- 1 by anti-IRS-1 antibody.

AB - Recently, a mutation substituting Leu for Ser323 in the α-subunit of the human insulin receptor has been identified in an insulin-resistant patient. The Leu323 mutation leads to a severe impairment in insulin binding without significantly altering the processing or cell surface expression of the receptor. In order to study how αβ half-receptors interact to form the insulin-binding site, we cotransfected NIH-3T3 cells with two insulin receptor cDNA constructs: a truncated insulin receptor lacking the C-terminal 43 amino acids (Δ43) and the full-length Leu323 mutant receptor. A clonal cell line from cotransfected cells expresses a hybrid receptor consisting of a Leu323 half-receptor and a Δ43 half- receptor. We demonstrate that the Leu323-Δ43 hybrid receptor binds insulin with high affinity. Furthermore, by cross-linking 125I-insulin to immobilized hybrid receptors, we show that only the αβ(Δ) half of the hybrid receptor binds insulin. Since the isolated half-insulin receptor has low affinity for insulin, this suggests that the addition of even a non- binding α-subunit can result in high affinity binding to the holoreceptor (αα(mut)β(Δ)β). Both β and β(Δ)-subunits of the Leu323-Δ43 hybrid receptor are phosphorylated in vivo and in vitro in an insulin-dependent manner, suggesting an intramolecular transphosphorylation mechanism and that the presence of the Leu323 mutant receptor that lacks an intrinsic high affinity binding site does not prevent the associated β-subunit from functioning either as a tyrosine kinase or as a phosphate acceptor in the hybrid insulin receptor molecule (αα(mut)β(Δ)β). Furthermore, we show that the hybrid receptor can phosphorylate insulin receptor substrate-1 (IRS- 1) in response to insulin and can be coimmunoprecipitated together with IRS- 1 by anti-IRS-1 antibody.

UR - http://www.scopus.com/inward/record.url?scp=0028243050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028243050&partnerID=8YFLogxK

M3 - Article

VL - 269

SP - 14912

EP - 14918

JO - Journal of Biological Chemistry

JF - Journal of Biological Chemistry

SN - 0021-9258

IS - 21

ER -